News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Androgen Receptor Inhibition Increases MHC Class I Expression in Prostate Cancer
Dec 11, 2024, 05:14

Androgen Receptor Inhibition Increases MHC Class I Expression in Prostate Cancer

Elizabeth McKenna, Executive Director of Cancer Discovery at the American Association for Cancer Research, shared a post on X:

“Now online in Cancer Discovery Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer -by Lisa Chesner, Felix Feng, Amy Moran, and colleagues.”

Elizabeth McKenna

Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer.

Authors: Lisa N. Chesner, Fanny Polesso, Julie N. Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg, Rajdeep Das, Tanushree Shenoy, Martin Sjöström, Faming Zhao, Ya-Mei Hu, Simon Linder, William S. Chen, Reed M. Hawkins, Raunak Shrestha, Xiaolin Zhu, Adam Foye, Haolong Li, Lisa M. Kim, Megha Bhalla, Thomas O’loughlin, Duygu Kuzuoglu-Ozturk, Junjie T. Hua, Michelle L. Badura, Scott Wilkinson, Shana Y. Trostel, Andries M. Bergman, Davide Ruggero, Charles G. Drake, Adam G. Sowalsky, Lawrence Fong, Matthew R. Cooperberg, Wilbert Zwart, Xiangnan Guan, Alan Ashworth, Zheng Xia, David A. Quigley, Luke A. Gilbert, Felix Y. Feng, Amy E. Moran.

MHC

Adam Foye Adam G. Sowalsky Alan Ashworth Alexis K. Smith Amy E. Moran Amy Moran Andries M. Bergman Androgen Receptor Arian Lundberg cancer Cancer Discovery Charles G. Drake David A. Quigley Davide Ruggero Duygu Kuzuoglu-Ozturk Elizabeth McKenna Faming Zhao Fanny Polesso Felix Feng Felix Y. Feng Haolong Li Jessica E. Hawley Julie N. Graff Junjie T. Hua Lawrence Fong Lisa Chesner Lisa M. Kim Lisa N. Chesner Luke A. Gilbert Martin Sjöström Matthew R. Cooperberg Megha Bhalla Michelle L. Badura OncoDaily Oncology prostate cancer Rajdeep Das Raunak Shrestha Reed M. Hawkins Scott Wilkinson Shana Y. Trostel Simon Linder Tanushree Shenoy Thomas O'loughlin Wilbert Zwart William S. Chen Xiangnan Guan Xiaolin Zhu Ya-Mei Hu Zheng Xia
Special Coverage
Science
May 25, 2025, 17:57
Edward Christopher Dee: Shedding Light on Cancer Care for SGM People Around the World
Blog
May 25, 2025, 17:43
Robert F. Kennedy, Jr.: HHS and Canadian Food Inspection Agency Discuss Joint Study on Avian Flu Immunity
Blog
May 25, 2025, 17:30
Debbie Denardi: Looking Forward to Attending ASCO25
Blog
May 25, 2025, 17:20
Victor Bultó: Cancer Care Enters a New Era as Today’s Patient Mindsets, Needs, and Expectations Evolve
Science
May 25, 2025, 17:15
Oscar Tahuahua: Treatment De-escalation, Emerging Biomarkers and Survivorship Care in Testicular Cancer
Blog
May 25, 2025, 17:10
Michael Lemma Wins ASCO IDEA and IDEA-PC Award of 2025
Blog
May 25, 2025, 17:02
Eric Singhi: Phase 3 HERTHENA-Lung02 Study
Blog
May 25, 2025, 16:51
Final Call for PSOGI 2025 Abstract Submissions is by June 1
Blog
May 25, 2025, 16:48
SIOP Europe Highlights Childhood Cancer Inequalities During European Week Against Cancer
Blog
May 25, 2025, 16:39
Monica-Emilia Chirilă: Grateful for the Opportunity to Organise the Radiation Therapy Sessions at the 5th Young Oncologists Forum
Blog
May 25, 2025, 16:36
Patrizia Giannatempo: Proud to Be Part of the ARON Project That Made the Unimaginable Happen
Blog
May 25, 2025, 16:16
Guru Sonpavde: Role of Adjuvant Therapy in Current Perioperative Immunotherapy-Based Trials in Bladder Cancer